271 related articles for article (PubMed ID: 25455508)
1. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
[TBL] [Abstract][Full Text] [Related]
2. Metabolic, hormonal and stress-related molecular changes in post-mortem pituitary glands from schizophrenia subjects.
Krishnamurthy D; Harris LW; Levin Y; Koutroukides TA; Rahmoune H; Pietsch S; Vanattou-Saifoudine N; Leweke FM; Guest PC; Bahn S
World J Biol Psychiatry; 2013 Sep; 14(7):478-89. PubMed ID: 22248022
[TBL] [Abstract][Full Text] [Related]
3. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
4. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
[TBL] [Abstract][Full Text] [Related]
5. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
Weigelt K; Carvalho LA; Drexhage RC; Wijkhuijs A; de Wit H; van Beveren NJ; Birkenhäger TK; Bergink V; Drexhage HA
Brain Behav Immun; 2011 Aug; 25(6):1162-9. PubMed ID: 21421043
[TBL] [Abstract][Full Text] [Related]
6. Near-infrared spectroscopic study of frontopolar activation during face-to-face conversation in major depressive disorder and bipolar disorder.
Takei Y; Suda M; Aoyama Y; Sakurai N; Tagawa M; Motegi T; Yamaguchi M; Narita K; Fukuda M
J Psychiatr Res; 2014 Oct; 57():74-83. PubMed ID: 25056175
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine abnormalities associated with untreated first episode patients with major depressive disorder and bipolar disorder.
Feng G; Kang C; Yuan J; Zhang Y; Wei Y; Xu L; Zhou F; Fan X; Yang J
Psychoneuroendocrinology; 2019 Sep; 107():119-123. PubMed ID: 31125758
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Proteomic Approach for Discriminating Major Depressive Disorder and Bipolar Disorder by Multiple Reaction Monitoring-Mass Spectrometry.
Shin D; Rhee SJ; Lee J; Yeo I; Do M; Joo EJ; Jung HY; Roh S; Lee SH; Kim H; Bang M; Lee KY; Kwon JS; Ha K; Ahn YM; Kim Y
J Proteome Res; 2021 Jun; 20(6):3188-3203. PubMed ID: 33960196
[TBL] [Abstract][Full Text] [Related]
9. Identification of altered protein expression in major depressive disorder and bipolar disorder patients using liquid chromatography-tandem mass spectrometry.
Kim H; Rhee SJ; Lee H; Han D; Lee TY; Kim M; Kim EY; Kwon JS; Shin H; Kim H; Ahn YM; Ha K
Psychiatry Res; 2021 May; 299():113850. PubMed ID: 33711561
[TBL] [Abstract][Full Text] [Related]
10. Sociodemographic and clinical features of bipolar disorder patients misdiagnosed with major depressive disorder in China.
Xiang YT; Zhang L; Wang G; Hu C; Ungvari GS; Dickerson FB; Kilbourne AM; Si TM; Fang YR; Lu Z; Yang HC; Lai KY; Lee EH; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
Bipolar Disord; 2013 Mar; 15(2):199-205. PubMed ID: 23437963
[TBL] [Abstract][Full Text] [Related]
11. Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients.
Stelzhammer V; Haenisch F; Chan MK; Cooper JD; Steiner J; Steeb H; Martins-de-Souza D; Rahmoune H; Guest PC; Bahn S
Int J Neuropsychopharmacol; 2014 Oct; 17(10):1599-608. PubMed ID: 24901538
[TBL] [Abstract][Full Text] [Related]
12. Prefrontal activation in response to emotional words in patients with bipolar disorder and major depressive disorder.
Matsubara T; Matsuo K; Nakashima M; Nakano M; Harada K; Watanuki T; Egashira K; Watanabe Y
Neuroimage; 2014 Jan; 85 Pt 1():489-97. PubMed ID: 23643923
[TBL] [Abstract][Full Text] [Related]
13. Pituitary volume in patients with bipolar disorder and their first-degree relatives.
Takahashi T; Walterfang M; Wood SJ; Kempton MJ; Jogia J; Lorenzetti V; Soulsby B; Suzuki M; Velakoulis D; Pantelis C; Frangou S
J Affect Disord; 2010 Aug; 124(3):256-61. PubMed ID: 20022640
[TBL] [Abstract][Full Text] [Related]
14. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder.
Lee MY; Kim EY; Kim SH; Cho KC; Ha K; Kim KP; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():60-8. PubMed ID: 27105922
[TBL] [Abstract][Full Text] [Related]
15. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
Novikova SI; He F; Cutrufello NJ; Lidow MS
Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
[TBL] [Abstract][Full Text] [Related]
16. Distinct proteomic profiles in prefrontal subareas of elderly major depressive disorder and bipolar disorder patients.
Qi YJ; Lu YR; Shi LG; Demmers JAA; Bezstarosti K; Rijkers E; Balesar R; Swaab D; Bao AM
Transl Psychiatry; 2022 Jul; 12(1):275. PubMed ID: 35821008
[TBL] [Abstract][Full Text] [Related]
17. Proteomic approaches to identify blood-based biomarkers for depression and bipolar disorders.
Preece RL; Han SYS; Bahn S
Expert Rev Proteomics; 2018 Apr; 15(4):325-340. PubMed ID: 29466886
[TBL] [Abstract][Full Text] [Related]
18. Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival.
Herberth M; Koethe D; Levin Y; Schwarz E; Krzyszton ND; Schoeffmann S; Ruh H; Rahmoune H; Kranaster L; Schoenborn T; Leweke MF; Guest PC; Bahn S
Proteomics; 2011 Jan; 11(1):94-105. PubMed ID: 21182197
[TBL] [Abstract][Full Text] [Related]
19. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in major depressive disorder patients.
Tanaka Y; Ishitobi Y; Maruyama Y; Kawano A; Ando T; Okamoto S; Kanehisa M; Higuma H; Ninomiya T; Tsuru J; Hanada H; Kodama K; Isogawa K; Akiyoshi J
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):220-4. PubMed ID: 22063648
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in major depressive disorder: the role of mass spectrometry.
Woods AG; Iosifescu DV; Darie CC
Adv Exp Med Biol; 2014; 806():545-60. PubMed ID: 24952202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
